Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Find | OTHER |
| Cameroon Ministry of Public Health | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
According to the WHO, contact tracing - along with robust testing, isolation, and care of cases is a key strategy for interrupting chains of transmission of SARS-CoV-2 and reducing mortality associated with COVID-19. Contact tracing, however, has a number of challenges. These include incomplete identification of contacts, inefficiencies in paper-based reporting systems, complex data management requirements, and delays in the identification of contacts and testing of contacts. In many settings, contact tracing has proven to be too resource-intensive to implement at scale, especially with higher levels of community transmission, highlighting the need for more efficient contact tracing approaches. Digital tools afford the possibility of strengthening contact tracing for COVID-19, in a more efficient way. However, there is limited evidence of the effectiveness and impact of these tools in the COVID-19 response, including contact tracing.
This study proposes to compare the cascade of care between two strategies for COVID-19 contact tracing of SARS-CoV-2 infected index patients in Cameroon. In one strategy (intervention), the health facilities and health district testing units will implement contact tracing using a digital tool developed to support the tracing and testing of contacts (addition of a digital contact tracing module to the main platform for COVID-19 testing in Cameroon (Mamal Pro app)). This strategy will be compared to the standard contact tracing process (control), based on the current routine approach (use of the Mamal Pro application without the digital contact tracing module).
The study's general objective is to assess the effectiveness, feasibility, acceptability, and cost associated with the addition of a Mamal Pro digital contact tracing module to the Mamal Pro app in improving COVID-19 contact tracing and testing in Littoral, Cameroon.
Specific objectives are:
Primary objective: To determine the effectiveness of the use of a Mamal Pro digital contact tracing module added to the Mamal Pro app in improving COVID-19 contact tracing and testing compared to the SOC as measured by:
Secondary objectives:
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Standard of care model (SOC) | No Intervention | This model is based on the standard of care recommended by the Cameroon National COVID-19 response program. | |
| Intervention model (ITV) | Experimental | Implementation of the contact tracing using a digitalized process (addition of the Mamal Pro digital contact tracing module to the Mamal Pro app). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Digital based contact tracing | Other |
|
| Measure | Description | Time Frame |
|---|---|---|
| Successful contact tracing | The primary outcome is the proportion of contacts declared by the index case who are successfully called by the district contact tracing unit and the proportion of contacts who receive SARS-CoV-2 testing, as per MOH standard testing procedures. | 10 days |
| Measure | Description | Time Frame |
|---|---|---|
| Contacts testing positive for SARS-CoV-2 infection. | The proportion of contacts testing positive for SARS-CoV2 infection | 10 days |
| Feasibility of the intervention model of contact tracing |
|
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Boris Tchakounte Youngui, MD, MPH | Elizabeth Glaser Pediatric AIDS Foundation | Principal Investigator |
| Godfrey Woelk, PhD, MCOMMH | Elizabeth Glaser Pediatric AIDS Foundation | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Bonanjo Integrated Health Center | Douala | Littoral Region | Cameroon | |||
| Bonassama District COVID testing unit |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 40017704 | Derived | Songane M, Tchakounte Youngui B, Mambo A, Bonabe G, Djikeussi T, Epee E, Tsigaing PN, Ndongo MLA, Mayap Njoukam C, Kana R, Tenkeu SZ, Simo L, Kouatchouang AV, Machekano R, Zoung-Kanyi Bissek AC, Tchendjou P, Tiam A, Guay L, Suleiman K, Akinwusi O, Kadam R, Akugizibwe P, Mukherjee S, Woelk G, Tchounga B. Using an app for COVID-19 contact tracing costs less per person traced than manual tracing: microcosting analysis of a randomised trial in Cameroon. BMJ Public Health. 2025 Jan 21;2(Suppl 1):e001064. doi: 10.1136/bmjph-2024-001064. eCollection 2024 Jul. | |
| 39109192 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a cluster randomized trial conducted in eight (8) Health Districts with a high number of people being tested for SARS-CoV-2 in the Littoral region in Cameroon, comparing two strategies for COVID-19 contact tracing of SARS-CoV-2 infected index patients:
The randomization unit (cluster) will be the district with selected testing units and/or health facilities where SARS-CoV-2 infected patients (index cases) are diagnosed.
Not provided
Not provided
Not provided
Not provided
|
| 4 months |
| Acceptability intervention model of contact tracing by the index cases (negative and positive) and health care workers |
| 4 months |
| Cost of the intervention | Cost estimates for using Mamal Pro digital contact tracing module to trace contacts, and cost per contact traced. | 4 months |
| Timely communication with contacts | Time (days) between receipt of contact list and contacts' call attempts | 4 months |
| SMS sent | Proportion of SMS delivered, (numerator: SMS sent, denominator: phone numbers) | 4 months |
| Douala |
| Littoral Region |
| Cameroon |
| Bonassama district hospital | Douala | Littoral Region | Cameroon |
| Cité des palmiers District COVID testing unit | Douala | Littoral Region | Cameroon |
| Cité des palmiers district hospital | Douala | Littoral Region | Cameroon |
| CMA Bonamoussadi | Douala | Littoral Region | Cameroon |
| CMA Nyala | Douala | Littoral Region | Cameroon |
| CMA Soboum hospital | Douala | Littoral Region | Cameroon |
| Deido District COVID testing unit | Douala | Littoral Region | Cameroon |
| Deido district hospital | Douala | Littoral Region | Cameroon |
| General Hospital Douala | Douala | Littoral Region | Cameroon |
| Gynecological-Obstetric and Pediatric Hospital Douala (HGOPED) | Douala | Littoral Region | Cameroon |
| Japoma District COVID testing unit | Douala | Littoral Region | Cameroon |
| Laquintinie Hospital | Douala | Littoral Region | Cameroon |
| Logbaba District COVID testing unit | Douala | Littoral Region | Cameroon |
| Logbaba district hospital | Douala | Littoral Region | Cameroon |
| Mbangue District COVID testing unit | Douala | Littoral Region | Cameroon |
| Mboppi Baptist hospital | Douala | Littoral Region | Cameroon |
| New Bell District COVID testing unit | Douala | Littoral Region | Cameroon |
| New Bell district hospital | Douala | Littoral Region | Cameroon |
| Nylon District COVID testing unit | Douala | Littoral Region | Cameroon |
| Nylon district hospital | Douala | Littoral Region | Cameroon |
| Derived |
| Tchakounte Youngui B, Mambo A, Machekano R, Kana R, Epee E, Tenkeu SZ, Tsigaing PN, Ndongo MLA, Njoukam CM, Bichara L, Katcho TD, Mbunka MA, Longla TA, Simo L, Kouatchouang AV, Tchendjou P, Tiam A, Guay L, Suleiman K, Akinwusi O, Kadam R, Akugizibwe P, Songane M, Woelk G, Tchounga BK; DTECT study group. Improving COVID-19 contact tracing and testing of exposed individuals in Cameroon using digital health technology: a cluster randomised trial. EClinicalMedicine. 2024 Jul 13;74:102730. doi: 10.1016/j.eclinm.2024.102730. eCollection 2024 Aug. |
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
| D014777 | Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided